BioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025
BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, has announced its participation in five upcoming investor conferences in May and June 2025. The company will attend the Craig-Hallum Institutional Investor Conference (May 28, Minneapolis), Benchmark Healthcare House Call Virtual Conference (May 29), Jefferies Global Life Sciences Conference (June 3-5, New York), Wolfe Research Small & Mid-Cap Conference (June 5, New York), and Northland Growth Conference (June 25, Virtual).
BioLife Solutions (NASDAQ: BLFS), un'azienda leader nello sviluppo e fornitura di prodotti e servizi per la bioproduzione nel mercato della terapia cellulare e genica, ha annunciato la sua partecipazione a cinque conferenze per investitori previste per maggio e giugno 2025. La società sarà presente al Craig-Hallum Institutional Investor Conference (28 maggio, Minneapolis), al Benchmark Healthcare House Call Virtual Conference (29 maggio), al Jefferies Global Life Sciences Conference (3-5 giugno, New York), al Wolfe Research Small & Mid-Cap Conference (5 giugno, New York) e al Northland Growth Conference (25 giugno, virtuale).
BioLife Solutions (NASDAQ: BLFS), un desarrollador y proveedor líder de productos y servicios de bioproducción para el mercado de terapias celulares y génicas, ha anunciado su participación en cinco conferencias para inversores que se celebrarán en mayo y junio de 2025. La compañía asistirá a la Craig-Hallum Institutional Investor Conference (28 de mayo, Minneapolis), la Benchmark Healthcare House Call Virtual Conference (29 de mayo), la Jefferies Global Life Sciences Conference (3-5 de junio, Nueva York), la Wolfe Research Small & Mid-Cap Conference (5 de junio, Nueva York) y la Northland Growth Conference (25 de junio, virtual).
BioLife Solutions (NASDAQ: BLFS)는 세포 및 유전자 치료 시장을 위한 바이오생산 제품 및 서비스를 개발·공급하는 선도 기업으로, 2025년 5월과 6월에 열리는 다섯 개의 투자자 컨퍼런스에 참가할 예정임을 발표했습니다. 회사는 Craig-Hallum Institutional Investor Conference(5월 28일, 미니애폴리스), Benchmark Healthcare House Call Virtual Conference(5월 29일), Jefferies Global Life Sciences Conference(6월 3-5일, 뉴욕), Wolfe Research Small & Mid-Cap Conference(6월 5일, 뉴욕), 그리고 Northland Growth Conference(6월 25일, 온라인)에 참석할 예정입니다.
BioLife Solutions (NASDAQ : BLFS), un acteur majeur dans le développement et la fourniture de produits et services de bioproduction pour le marché des thérapies cellulaires et géniques, a annoncé sa participation à cinq conférences investisseurs prévues en mai et juin 2025. La société assistera à la Craig-Hallum Institutional Investor Conference (28 mai, Minneapolis), à la Benchmark Healthcare House Call Virtual Conference (29 mai), à la Jefferies Global Life Sciences Conference (3-5 juin, New York), à la Wolfe Research Small & Mid-Cap Conference (5 juin, New York) et à la Northland Growth Conference (25 juin, virtuelle).
BioLife Solutions (NASDAQ: BLFS), ein führender Entwickler und Anbieter von Bioproduktionsprodukten und -dienstleistungen für den Markt der Zell- und Gentherapie, hat seine Teilnahme an fünf bevorstehenden Investorenkonferenzen im Mai und Juni 2025 angekündigt. Das Unternehmen wird an der Craig-Hallum Institutional Investor Conference (28. Mai, Minneapolis), der Benchmark Healthcare House Call Virtual Conference (29. Mai), der Jefferies Global Life Sciences Conference (3.-5. Juni, New York), der Wolfe Research Small & Mid-Cap Conference (5. Juni, New York) und der Northland Growth Conference (25. Juni, virtuell) teilnehmen.
- None.
- None.
- 22nd Annual Craig-Hallum Institutional Investor Conference
- May 28, 2025
Minneapolis, MN at the Renaissance Hotel
- Benchmark 2025 Healthcare House Call Virtual Conference
- May 29, 2025
- Virtual
- Jefferies Global Life Sciences Conference
- June 3 – 5, 2025
New York, NY at the Marriott Marquis
- Wolfe Research Small & Mid-Cap Conference
- June 5, 2025
New York, NY at Wolfe Headquarters
- Northland Growth Conference 2025
- June 25, 2025
- Virtual
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-may-and-june-2025-302454438.html
SOURCE BioLife Solutions, Inc.
FAQ
Which investor conferences will BioLife Solutions (BLFS) attend in May and June 2025?
When is BioLife Solutions (BLFS) presenting at the Jefferies Global Life Sciences Conference 2025?
How many virtual conferences will BioLife Solutions (BLFS) attend in May-June 2025?
What is BioLife Solutions' (BLFS) main business focus?
